|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
On December 11, 2024, Xenetic Biosciences, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the stockholders of the Company voted on the following four proposals and cast their votes as described below.
|
|
1.
|
The Company's stockholders approved the election of the following six nominees with each director receiving votes as follows:
|
|
Name
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
|
Dr. Grigory Borisenko
|
|
486,395
|
|
18,588
|
|
391,780
|
|
Mr. Firdaus Jal Dastoor
|
|
470,826
|
|
34,157
|
|
391,780
|
|
Dr. Dmitry Genkin
|
|
483,081
|
|
21,902
|
|
391,780
|
|
Dr. Roger Kornberg
|
|
458,022
|
|
46,961
|
|
391,780
|
|
Mr. Moshe Mizrahy
|
|
482,135
|
|
22,848
|
|
391,780
|
|
Mr. Alexey Vinogradov
|
|
485,179
|
|
19,804
|
|
391,780
|
|
|
2.
|
The Company's stockholders voted upon and approved the ratification of the selection of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. The votes on this proposal were as follows:
|
|
For
|
|
Against
|
|
Abstained
|
|
Broker Non-Votes
|
|
878,207
|
|
15,137
|
|
3,419
|
|
-
|
|
|
3.
|
The Company's stockholders voted upon and approved, on a non-binding, advisory basis, the Company's named executive officer compensation. The votes on this proposal were as follows:
|
|
For
|
|
Against
|
|
Abstained
|
|
Broker Non-Votes
|
|
462,285
|
|
40,600
|
|
2,098
|
|
391,780
|
|
|
4.
|
The Company's stockholders voted upon and approved, on a non-binding, advisory basis, the frequency of holding future votes regarding named executive officer compensation ("Say on Frequency") every 1 year. The votes on this proposal were as follows:
|
|
1 Year
|
|
2 Years
|
|
3 Years
|
|
Abstained
|
|
Broker Non-Votes
|
|
470,918
|
|
3,600
|
|
3,631
|
|
26,834
|
|
391,780
|
|
|
|
Consistent with the recommendation of the Company's Board of Directors, as set forth in the 2024 Proxy Statement, and based on the results of this non-binding advisory vote, it is the Company's intent that future advisory stockholder votes on the compensation of its named executive officers will be held annually and included in the Company's proxy materials for each annual meeting until the next required vote on Say on Frequency.
|
No other matters were considered or voted upon at the Annual Meeting.
